AOD-9604 is a synthetic peptide that mimics the C-terminal fragment of human growth hormone. It specifically targets adipose tissue to stimulate lipolysis and inhibit lipogenesis, effectively reducing body fat without impacting blood sugar or IGF-1 levels. By enhancing metabolic signaling and fat oxidation, it promotes significant weight loss while maintaining an excellent safety profile for users.

For high-purity research peptides, Prime Lab Peptides offers premium-grade compounds specifically synthesized for scientific and metabolic research. Our commitment to rigorous testing and consistent quality ensures reliable data for every laboratory application. Explore our catalog today to find the precise tools needed for your next breakthrough.

How Does AOD-9604 Stimulate Lipolysis in Adipose Tissue?

AOD-9604 effectively stimulates lipolysis by activating specific metabolic pathways[1] within fat cells, primarily through the increased expression of beta-3 adrenergic receptors. This targeted activation triggers hormone-sensitive lipase, which efficiently breaks down stored triglycerides into free fatty acids. Consequently, the peptide accelerates fat oxidation and metabolic rate without negatively impacting insulin sensitivity or blood glucose levels.

cAMP Activation:

AOD-9604 increases intracellular cyclic AMP (cAMP) levels in adipocytes, which acts as a key signaling molecule in fat metabolism. This elevation activates protein kinase A, a central regulator of lipolysis. As a result, enzymatic processes that break down stored fat are accelerated, enhancing overall lipolytic efficiency.

Lipase Activation:

The peptide stimulates hormone-sensitive lipase within fat cells, which plays a direct role in fat breakdown. This enzyme targets stored triglycerides and converts them into free fatty acids and glycerol. Consequently, it enables efficient mobilization of stored fat, making it readily available for metabolic use.

Energy Utilization:

AOD-9604 promotes the release of fatty acids into circulation, allowing them to be transported to energy-demanding tissues. These fatty acids undergo oxidation in cellular mitochondria to produce energy. This process supports a metabolic shift from fat storage toward increased energy expenditure and improved metabolic activity.

How Does AOD-9604 Influence Metabolic Pathways Without Affecting Growth Hormone Receptors?

AOD-9604 strategically influences metabolism by mimicking the specific lipolytic region of human growth hormone. By avoiding interaction with growth hormone receptors[2], it prevents unwanted systemic hormonal effects like IGF-1 elevation or insulin resistance. Instead, it targets adipose tissue directly to stimulate fat breakdown, providing a focused metabolic enhancement that safely promotes fat loss without growth-related risks.

Additionally, this selective mechanism allows targeted fat metabolism without altering glucose regulation. Studies indicate that AOD-9604 promotes fat oxidation and energy expenditure while maintaining insulin sensitivity, aligning with established research standards for safety and metabolic specificity, making it a unique compound for metabolic research focused on adipose-specific activity.

What Role Does AOD-9604 Play in Inhibiting Lipogenesis?

AOD-9604 effectively inhibits lipogenesis by downregulating the specific enzymes responsible for converting excess dietary nutrients into stored adipose tissue. By suppressing these lipogenic pathways, it significantly reduces new fat formation. Simultaneously, it promotes active fat breakdown through lipolysis, creating a dual-action metabolic environment that favors a leaner body composition without interfering with systemic growth hormone levels.
Key mechanisms involved include:

• Reduction in enzymes responsible for triglyceride synthesis
• Suppression of pathways that convert glucose into stored fat
• Enhanced signaling for fatty acid breakdown and mobilization
• Maintenance of metabolic balance without affecting GH receptors

This dual-action mechanism, derived from its origin as a growth hormone[3] fragment, creates a metabolic environment where fat accumulation is minimized. By limiting triglyceride synthesis and enhancing fatty acid release, AOD-9604 supports a shift toward energy utilization rather than fat storage in metabolic study models. This improves metabolic efficiency and allows researchers to better analyze fat metabolism pathways and energy balance dynamics.

How Is AOD-9604 Used in Scientific Metabolic Research Models?

AOD-9604 is extensively used in metabolic research to study fat reduction [4], energy expenditure, and complex adipose tissue signaling. Its unique ability to enhance lipolysis and fat oxidation in experimental models makes it a vital tool for understanding obesity. By isolating these specific metabolic pathways, researchers can investigate targeted fat loss without the systemic hormonal risks.

Animal studies have demonstrated reduced body weight gain and increased fat metabolism without adverse effects on insulin sensitivity. Researchers use it to investigate obesity-related pathways, adipocyte function, and potential therapeutic targets for metabolic disorders. This makes AOD-9604 a valuable tool for studying safe fat reduction mechanisms and long-term metabolic regulation.

Choose Prime Lab Peptides for Reliable Metabolic Compounds

Researchers struggle with reliable metabolic compounds due to inconsistent peptide purity, poor manufacturing standards, and a lack of transparent testing data. These issues directly impact experimental accuracy, reproducibility, and overall research outcomes, especially in sensitive areas like lipolysis and metabolic pathway analysis.

The solution is choosing a trusted provider like Prime Lab Peptides. Their rigorously tested compounds ensure high purity, batch-to-batch consistency, and reliable performance in every experiment. With strict quality control and verified standards, you can conduct precise metabolic research confidently while achieving reproducible, accurate, and scientifically valid outcomes across all studies.

FAQs

What is AOD-9604 peptide used for in research?
AOD-9604 is used in research to study fat metabolism, lipolysis, and obesity-related biological pathways. It helps researchers analyze how adipose tissue responds to metabolic stimulation, enhances fat oxidation processes, and supports investigations into safe and targeted fat reduction mechanisms.

Does AOD-9604 affect insulin sensitivity?
AOD-9604 does not significantly affect insulin sensitivity in most research findings. Studies show it promotes fat metabolism and lipolysis without disrupting glucose regulation, making it suitable for metabolic research models that require stable insulin response and balanced energy metabolism.

Is AOD-9604 similar to human growth hormone?
AOD-9604 is a modified fragment of human growth hormone that mimics its fat-burning properties. However, it does not bind to growth hormone receptors or stimulate IGF-1 production, allowing targeted lipolytic effects without systemic hormonal changes in research settings.

How does AOD-9604 enhance fat oxidation?
 AOD-9604 enhances fat oxidation by stimulating lipolysis and increasing the release of free fatty acids into circulation. These fatty acids are then utilized as energy within cells, improving metabolic efficiency and supporting detailed studies of fat utilization and energy balance.

References:

1- Nelson, A. E., Meinhardt, U., Hansen, J. L., Birzniece, V., Clifford, D., & Ho, K. K. Y. (2014). Pharmacokinetics and metabolism of AOD9604 in human subjects. Clinical Endocrinology, 81(3), 324–330. https://pubmed.ncbi.nlm.nih.gov/25208511/

2- Ng, F. M., & colleagues. (2022). Human growth hormone fragment (176–191) and its metabolic effects. International Journal of Molecular Sciences, 23(13), 1–15. https://pmc.ncbi.nlm.nih.gov/articles/PMC9249349/

3- Brooks, A. J., & Waters, M. J. (2018). The growth hormone receptor: Mechanism of activation and signal transduction. International Journal of Molecular Sciences, 19(5), 1–20. https://pmc.ncbi.nlm.nih.gov/articles/PMC5816795/

4- Heffernan, M. A., Thorburn, A. W., Fam, B., Summers, R. J., & Ng, F. M. (2001). Increase of fat oxidation and weight loss in obese mice treated with a growth hormone fragment. Endocrinology, 142(12), 5182–5189. https://pubmed.ncbi.nlm.nih.gov/11673763/